Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

Background Hepatitis B virus (HBV) is a common cause of viral ... to HBsAg testing and also to ascertain likely cause of weakly positive (grayzone) results. Results During the 17 month study ...

Blood tests are a routine part of your prenatal care. Here's everything you need to know about what you can expect.

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

People are also enquiring whether cancer will be a disease of the past like polio or measles after the vaccine is available ...

Feb. 10-16 is SexPlus Week — here's what seniors should know about staying safe while having an active sex life.

President Trump and his proposed Health and Human Services leadership team have asked serious questions about the safety of ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.

Cook County officials and health care providers gathered at a Friday news conference to remind residents to get tested and ...

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts ...

The Nasdaq is one of the top three most-followed stock market indices in the United States, comprising over 2,500 stocks.

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds momentum with both Fast Track and Orphan Drug Designations.